Research theme for competitive and other funds (3)：
2024 - 2027 Development of new gene panel system for molecular classification of endometrial cancer and genetic analysis to search for therapeutic targets
2022 - 2025 Comprehensive Search for Early Diagnostic Markers and Therapeutic Targets for Cervical Cancer Using Circular RNA in Blood
2016 - 2019 Elucidation of the miRNA-EZH2 feedback loop regulating endometrial cancer microenvironment
Papers (45)：
Yosuke Konno, Michinori Mayama, Kazuhiro Takehara, Yoshihito Yokoyama, Jiro Suzuki, Nobuyuki Susumu, Kenichi Harano, Satoshi Nakagawa, Toru Nakanishi, Wataru Yamagami, et al. Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of gynecologic oncology. 2024
Shogo Shigeta, Yosuke Konno, Yoshito Terai, Tohru Morisada, Hideki Tokunaga, Tsukasa Baba, Yoichi Kobayashi, Satoru Nagase. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee. Japanese journal of clinical oncology. 2023
Yu Miao, Yosuke Konno, Baojin Wang, Lin Zhu, Tianyue Zhai, Kei Ihira, Noriko Kobayashi, Hidemichi Watari, Xin Jin, Junming Yue, et al. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer. Journal of Translational Medicine. 2023. 21. 1
Tatsuya Kato, Chisa Shimada, Fumi Kato, Hiromi Okada-Kanno, Mahito Takeda, Daisuke Endo, Kei Ihira, Takashi Mitamura, Yosuke Konno, Noriaki Sakuragi, et al. Patterns and predictors of site-specific recurrence in cervical cancer after radical hysterectomy. The journal of obstetrics and gynaecology research. 2022
Hiroyuki Yamazaki, Hiroshi Asano, Kanako C Hatanaka, Ryosuke Matsuoka, Yosuke Konno, Yoshihiro Matsuno, Yutaka Hatanaka, Hidemichi Watari. The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification. Cancer science. 2022. 113. 9. 3134-3147
